The average biological age of people in their 40s is 40-something. In their 50s it is 50-something. This is not a coincidence and it is not a useful benchmark, because commercial biological age tests are calibrated so that the population average lands on chronological age.
So the question behind the search has no table to answer it. What does have an answer is the spread: how far people scatter around their chronological age in each decade, how much of that scatter is real, and how much is the test disagreeing with itself.
The Verdict
Why the average is always your chronological age
Every mainstream biological age test is built by training a model to predict something in a reference population. The 2013 multi-tissue methylation clock was trained directly on chronological age across thousands of samples. A model fitted that way produces predictions that centre on the thing it was fitted to.
Later tests changed the training target without changing that property. PhenoAge was trained on a clinical-marker score built to predict mortality, and GrimAge on mortality itself using plasma proteins and smoking history. Both still report an age in years, and both are scaled so the reference population averages out at its own chronological age.
The practical consequence is worth stating plainly. If someone publishes a table of "average biological age by decade", the entries will be approximately 25, 35, 45, 55 and 65, and the table teaches nothing. The information is in the distribution around those numbers.
The number that actually varies
Researchers work with age acceleration, which is your result minus your chronological age, adjusted so the population average is zero. A positive value means you read older than people your age in that test's reference group. This residual is what the outcome studies actually analyse.
Pace-of-aging measures take a different route to the same idea. DunedinPACE reports a rate rather than an age, calibrated so that 1.0 means one year of biological aging per calendar year. A person at 1.15 is aging about 15% faster than the pace the cohort was calibrated against, and that statement is readable at any chronological age.
| Test family | What it reports | What that means for benchmarking |
|---|---|---|
| First-generation clocks trained on chronological age | An age in years | Centred on chronological age by construction. Reliability between repeat draws is the weakest of the families |
| Second-generation clocks trained on mortality or clinical markers | An age in years, plus a risk framing | Better outcome prediction. Still centred on chronological age, so the population average in any decade equals that decade |
| Pace-of-aging measures | A rate, where 1.0 is one biological year per calendar year | Sidesteps the average question entirely. There is no "average biological age" to report because the output is not an age |
| Glycan and immune-age tests | An age in years | Calibrated on the manufacturer reference population, which is smaller and differently composed than the large methylation cohorts |
What each decade actually looks like
Spread, not average, is what changes across the decades. The pattern below is consistent across the large methylation cohorts and is the frame worth using when reading your own report.
| Decade | Typical spread around chronological age | How to read a result here |
|---|---|---|
| 20s and early 30s | Almost always within a few years of chronological age | Least informative decade. Divergence has had little time to accumulate, and most of the gap you see is measurement variation rather than biology |
| Late 30s to 40s | Small gaps in either direction, widening through the decade | The first decade where a consistent gap starts to carry information. Weight, blood pressure, drinking, sleep debt and smoking history begin separating people |
| 50s | Results above chronological age become common | Reading older here is ordinary rather than alarming. Accumulated exposures and, for women, the menopause transition both push the number up in population data |
| 60s and beyond | The widest spread of any decade | The decade where the measures were most validated, because mortality and disease events are frequent enough for the association to be tested. A gap carries more weight here than at 35 |
One decade deserves particular care. In the 50s, reading older than your chronological age is the common case rather than the warning sign, and reports that flag it as a red result are describing the ordinary half of a distribution. For women, the years surrounding the final menstrual period bring a measurable shift in ApoB, insulin sensitivity and body composition that is captured by clocks trained on clinical markers.
How much of your gap is measurement noise
Reliability differs sharply between test generations. First-generation clocks show enough test-retest variation that repeated measurement of the same biological sample can return results several years apart. Principal-component versions of these clocks were developed specifically to address that instability, and they improved it substantially.
This sets a floor on what a result can tell you. A two-year gap on a first-generation clock is not distinguishable from measurement error. A gap that shows up on two separate draws, months apart, on the same test, is a different piece of evidence.
Test-to-test variation is not the only source of noise. Blood cell composition shifts with a recent infection and moves methylation readings, which is why a draw taken while you are unwell is worth repeating. Our guide to reading a biological age report covers the precision figures each provider publishes.
What a gap predicts, and what it does not
Age acceleration is associated with mortality and disease risk in large cohorts, and second-generation clocks predict those outcomes better than first-generation ones. That is a statement about populations. It supports the claim that a group with high acceleration has worse average outcomes than a group with low acceleration.
It does not convert into a personal life expectancy. No commercial test has been shown to forecast an individual's remaining years with useful precision, and none is regulated as a diagnostic. A biological age result is a research-derived summary statistic sold as a consumer product, and the gap between those two things is where most of the overclaiming happens.
A finding worth acting on is one that agrees with something else. If a raised result sits alongside a rising hsCRP, a climbing fasting insulin and worsening blood pressure, the standard panel is telling you the same thing at lower cost and on a faster timescale.
Using this on your own report
- Ignore the "average for your age" line. It is your chronological age, printed back at you, on every test.
- Read the gap, not the age. Age acceleration is the figure the research is built on.
- Discount small gaps. A couple of years in either direction is inside the measurement error of most consumer tests.
- Do not compare across test families. Different molecules, different reference groups, no like-for-like reading.
- Retest yearly at most, on the same test. The measures are built to resolve years, not quarters.
- Check the result against a standard panel. Agreement between the two is what makes a finding worth taking to a clinician.
Frequently Asked Questions
What is the average biological age for someone in their 40s?
It is their chronological age, and the same is true in every other decade. Commercial biological age tests are calibrated so that the average result in a reference population matches the average chronological age of that population. The average 44-year-old therefore returns a biological age near 44 on essentially every test on the market. The number that varies between people is the gap between the two, which researchers call age acceleration, and that is the figure worth reading.
Is it normal for biological age to be higher than chronological age in your 50s?
Yes. Roughly half of any reference population sits above their chronological age by definition, since the average is centred on it. In the 50s the drivers of an upward gap have had decades to accumulate: body weight, blood pressure, cumulative alcohol, smoking history, poor sleep and, in women, the metabolic shift around the menopause transition. A result a few years above your age in this decade is a common finding, not an outlier.
How big does the gap have to be before it means something?
Smaller gaps than most reports imply are inside the measurement error. Test-retest variation on first-generation methylation clocks is wide enough that a difference of a few years between two draws of the same sample is expected, and principal-component versions of the same clocks were developed specifically to reduce it. Treat a gap of a couple of years as uninformative on its own. A gap that is large, consistent across two separate draws, and matches what your standard panel shows is the version worth acting on.
Can your biological age be lower than your chronological age?
It can, and about half of a reference population will read that way. A lower result means your methylation, glycan or clinical marker profile resembles that of people younger than you within that test's reference group. It is not a measurement of how long you will live, and the size of a favourable gap does not translate into a number of extra years. Population studies link age acceleration to disease and mortality risk across large groups, which is a different claim from a personal forecast.
Does biological age keep rising as you get older?
The reported age rises with chronological age, because the tests are built to track it. What can change is the gap. Pace-of-aging measures make this clearer by reporting a rate rather than an age, so a result near 1.0 means you are aging at roughly one biological year per calendar year regardless of how old you are. That framing avoids the confusion of watching a number climb every year and reading it as decline.
Why do two different tests give me different biological ages?
Because they measure different things and are calibrated on different reference populations. A methylation clock reads DNA methylation patterns, a glycan test reads antibody sugar structures, and a clinical-marker score reads blood chemistry. Each is centred on the chronological age of its own reference cohort, and the cohorts differ in size, age range and geography. Comparing an age from one family against an age from another is not a like-for-like comparison, which is why tracking one test over time beats collecting several.
How often should I retest?
Yearly is enough for most people, and more often mainly produces noise. The underlying measures are built to detect change across years, and repeat draws taken a few months apart differ by amounts that overlap with measurement error. If you are tracking a specific change, the markers that move on a shorter timescale are the ordinary ones: fasting insulin, HbA1c, hsCRP, ApoB, blood pressure, VO2 max and resting heart rate.
Related
- What is biological age — how each family of test is built
- How to read a biological age report — the precision figures and what they cap
- Methylation clock vs immune age — the two test families side by side
- Best biological age test — five providers on one rubric
- How to lower biological age — what has moved the number in trials
- Does stress accelerate aging — why these tests cannot resolve a hard quarter
- Normal vs optimal ranges — why a reference range is not a target